Top Markets
Coin of the day
IR Biosciences Holdings Inc. IR Biosciences Holdings Inc.

IR Biosciences Holdings Inc.

IRBS
Rang in aandelen #40520
IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm.... IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for significant health challenges, including pulmonary fibrosis, influenza infections, and neutropenia caused by radiation. The company is also actively developing Homspera and its derivatives, Radilex and Viprovex. These compounds are designed to stimulate human stem cells, enhance immune system responses, offer anti-infective properties, serve as vaccine adjuvants, and promote wound healing. Founded in 1999, IR BioSciences Holdings, Inc. maintains its headquarters in Scottsdale, Arizona.
Aandeelprijs
$0.00006
Laatst gesynchroniseerd: 2025-07-15
Marktkapitalisatie
$128.12K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel IR Biosciences Holdings Inc. (IRBS)

Categorie

Koersgeschiedenis voor IR Biosciences Holdings Inc. (IRBS)
Hoogste slotkoers: $0.00 op 2025-07-01

Laagste slotkoers: $0.00 op 2023-06-01
Koersgeschiedenis van IR Biosciences Holdings Inc. van 2023 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2025 0.00%
2024 5,900.00%
2023 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE